Search
for
Sort by
Research 31–60 of 1000+
- Profile of tofacitinib citrate and its potential in the treatment of moderate-to-severe chronic plaque psoriasis
- Phenol in dermatology: updated evidence on efficacy and safety
- The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
- Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Serum Vitamin D levels and Alopecia areata- A hospital based case-control study from North-India
- Relapsing Polychondritis Following Alopecia Areata
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Serum Level of Macrophage Migration Inhibitory Factor (MIF) in Egyptians With Alopecia Areata and Its Relation to the Clinical Severity of the Disease
- Inhibition of T-cell activity in alopecia areata: recent developments and new directions
- Drug Armamentarium for alopecia areata
- Causal effects of glutamine and lipid-related metabolites on alopecia areata: A 2-sample Mendelian randomization study
- The Genetic Architecture of Alopecia Areata
- Treatment options for alopecia areata
- The Role of Serum Th1, Th2, and Th17 Cytokines in Patients with Alopecia Areata: Clinical Implications
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Alopecia areata – Current understanding and management
- An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
- Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Emerging Topical and Systemic JAK Inhibitors in Dermatology
- Oxidative Stress and Skin Diseases: The Role of Lipid Peroxidation
- The PI3K-Akt-mTOR and Associated Signaling Pathways as Molecular Drivers of Immune-Mediated Inflammatory Skin Diseases: Update on Therapeutic Strategy Using Natural and Synthetic Compounds
- Game Changers: Blockbuster Small-Molecule Drugs Approved by the FDA in 2024
- Advances in Cell-Mediated Drug Delivery for Dermatologic Diseases: Mechanisms and Current Applications
- Advances in Bioprinting to Model Immune‐Mediated Skin Diseases
- Features Associated With Quality of Life Impairment in Hidradenitis Suppurativa Patients